Andrew W. Pippas, MD

Georgia's Online Cancer Information Center

Andrew Pippas

Andrew W. Pippas, MD

Director of Clinical Oncology Research

Piedmont Columbus Regional - John B. Amos Cancer Center

Andrew W. Pippas, MD

Andrew Pippas

Director of Clinical Oncology Research

Piedmont Columbus Regional - John B. Amos Cancer Center

Dr. Andrew Pippas is medical director and director of clinical oncology research with the John B. Amos Cancer Center at Piedmont Columbus Regional in Columbus, Georgia. Dr. Pippas' research interests include gastrointestinal malignancies. A 2010 Distinguished Georgia Cancer Scholar, he a recipient of the National Institutes of Health's Physician Scientist Award. Dr. Pippas is board certified in Internal Medicine, Hematology, and Medical Oncology. He earned his Doctor of Medicine from the University of Utah School of Medicine in Salt Lake City, and completed his residency in internal medicine and a fellowship in medical oncology/ hematology at the Duke University Medical Center in Durham, North Carolina. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology.

About Us

Nominations open for the Cancer Patient Navigation and Cancer Community Service Awards

And for the first time, we are offering an incentive for nominations!

3/05/2026

Strange seats bring colon cancer awareness to Georgia bars, coffee shops

The AJC covers Georgia CORE's unique colon cancer awareness campaign, Weird Looking Stools, helping to raise awareness to look for the signs and symptoms of colon cancer.

10/21/2025

Georgia Cancer Trial Finders Provider Engagement Webinar

Join us for a 35-minute Georgia Cancer Trial Finders Provider Engagement Webinar on March 26 from 12:15–12:50 PM (ET) featuring Dr. Trevor Feinstein, Chief Medical Officer of Georgia CORE, and Dr. Crain Garrott, Past President of the Georgia Society of Clinical Oncology (GASCO).

Because many referrals to Georgia Cancer Trial Finders originate from clinical teams, increasing provider awareness of this res

3/13/2026

 Clinical Trials, Doctors & Cancer Centers